Omega Therapeutics Names Kaan Certel as CEO

Dow Jones

2024-11-15

By Kailyn Rhone

Omega Therapeutics appointed Kaan Certel as chief executive officer of the Cambridge, Mass.-based biotechnology company.

Certel, who has been Omega's chief business officer since May, will succeed Mahesh Karande, who decided to leave the company for personal reasons.

Certel is an industry veteran with over 20 years of experience in the biopharmaceutical field and academia. Before Omega, he served as the chief business officer for BioCity Biopharma.

Under its new leadership, the company plans to focus its capital resources on three prioritized programs in obesity, regenerative medicine and metabolic indications that will leverage its value proposition.

Write to Kailyn Rhone at kailyn.rhone@wsj.com

(END) Dow Jones Newswires

November 14, 2024 17:28 ET (22:28 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2483359601"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2483359601\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2483359601?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-15 06:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2483359601","market":"sg","top_or_hot":-1,"title":"Omega Therapeutics Names Kaan Certel as CEO","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Kailyn Rhone \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/OMGA\">Omega Therapeutics</a> appointed Kaan Certel as chief executive officer of the Cambridge, Mass.-based biotechnology company. \n</p>\n<p>\n  Certel, who has been Omega's chief business officer since May, will succeed Mahesh Karande, who decided to leave the company for personal reasons. \n</p>\n<p>\n  Certel is an industry veteran with over 20 years of experience in the biopharmaceutical field and academia. Before Omega, he served as the chief business officer for BioCity Biopharma. \n</p>\n<p>\n  Under its new leadership, the company plans to focus its capital resources on three prioritized programs in obesity, regenerative medicine and metabolic indications that will leverage its value proposition. \n</p>\n<p>\n  Write to Kailyn Rhone at kailyn.rhone@wsj.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 14, 2024 17:28 ET (22:28 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Omega Therapeutics Names Kaan Certel as CEO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOmega Therapeutics Names Kaan Certel as CEO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-11-15 06:28</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Kailyn Rhone \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/OMGA\">Omega Therapeutics</a> appointed Kaan Certel as chief executive officer of the Cambridge, Mass.-based biotechnology company. \n</p>\n<p>\n  Certel, who has been Omega's chief business officer since May, will succeed Mahesh Karande, who decided to leave the company for personal reasons. \n</p>\n<p>\n  Certel is an industry veteran with over 20 years of experience in the biopharmaceutical field and academia. Before Omega, he served as the chief business officer for BioCity Biopharma. \n</p>\n<p>\n  Under its new leadership, the company plans to focus its capital resources on three prioritized programs in obesity, regenerative medicine and metabolic indications that will leverage its value proposition. \n</p>\n<p>\n  Write to Kailyn Rhone at kailyn.rhone@wsj.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 14, 2024 17:28 ET (22:28 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OMGA","symbol_name":"Omega Therapeutics","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2483359601","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483359601","pubTimestamp":1731623280,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Omega Therapeutics appointed Kaan Certel as chief executive officer of the Cambridge, Mass.-based biotechnology company.Certel, who has been Omega's chief business officer since May, will succeed Mahesh Karande, who decided to leave the company for personal reasons.Certel is an industry veteran with over 20 years of experience in the biopharmaceutical field and academia. Before Omega, he served as the chief business officer for BioCity Biopharma.Under its new leadership, the company plans to focus its capital resources on three prioritized programs in obesity, regenerative medicine and metabolic indications that will leverage its value proposition.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OMGA":"Omega Therapeutics"},"translate_title":"Omega Therapeutics任命Kaan Certel为首席执行官","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OMGA":1},"content_text":"By Kailyn Rhone \n\n\nOmega Therapeutics appointed Kaan Certel as chief executive officer of the Cambridge, Mass.-based biotechnology company. \n\n\n  Certel, who has been Omega's chief business officer since May, will succeed Mahesh Karande, who decided to leave the company for personal reasons. \n\n\n  Certel is an industry veteran with over 20 years of experience in the biopharmaceutical field and academia. Before Omega, he served as the chief business officer for BioCity Biopharma. \n\n\n  Under its new leadership, the company plans to focus its capital resources on three prioritized programs in obesity, regenerative medicine and metabolic indications that will leverage its value proposition. \n\n\n  Write to Kailyn Rhone at kailyn.rhone@wsj.com \n\n\n  (END) Dow Jones Newswires\n\n\n  November 14, 2024 17:28 ET (22:28 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}